Company Overview of Proacta Inc.
Proacta Inc. develops and commercializes hypoxia-activated oncology drugs. It offers PR104, a hypoxia-selective small-molecule prodrug that is designed to improve the outcome of cancer patients by targeting cancer cells resistant to current treatments. Proacta Inc. was incorporated in 2004 and is based in San Diego, California.
4275 Executive Square
San Diego, CA 92037
Founded in 2004
Key Executives for Proacta Inc.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Proacta Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.